The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Avid Bioservices, a Tustin, California-based contract development and manufacturing organization (CDMO) of biopharmaceutical products derived from mammalian cell culture and a wholly owned subsidiary of Peregrine Pharmaceuticals, has provided an...
STA Pharmaceutical, a subsidiary of WuXi AppTec, has signed an investment agreement with the government of Shanghai, Jinshan District, China to build a new research & development (R&D) center.
The new facility will support WuXi STA’s...
Cell and Gene Therapy Catapult (CGT Catapult), a center of excellence funded by Innovate UK, the UK government’s innovation agency, to support cell-therapy organizations, has opened a cell- and gene- therapy manufacturing center in Stevenage,...
Grand River Aseptic Manufacturing (GRAM), a Grand Rapids, Michigan-based provider of sterile-manufacturing services, has purchased a Bausch+Ströbel fully integrated high-speed filling line with a SKAN isolator.
The Bausch+Ströbel filler can fill...
Dipharma, a Baranzate, Italy-headquartered active pharmaceutical ingredients manufacturer, has agreed to acquire Kalexsyn, a Kalamazoo, Michigan-headquartered contract research organization (CRO) providing chemistry services to the biotechnology...
Catalent Pharma Solutions plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its Somerset, New Jersey facility and headquarters.
The investment will see the site focus on preclinical to clinical...
AMRI, a contract research, development, and manufacturing organization, has renewed a 10-year contract worth up to $39.5 million with the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN). The renewal means AMRI will...
Sharp Packaging Services, a part of UDG Healthcare and a company in contract packaging and clinical supply services, has invested $11 million to increase its global cold-storage and syringe assembly capacity.
The additional investment in Groninger...
Phoenix Molecular Designs (PhoenixMD), a Vancouver, Canada-headquartered biopharmaceutical company designing cancer therapeutics, has partnered with STA Pharmaceutical, a WuXi AppTec company, to manufacture PMD-026, a first-in-class, specific...
Noramco, a Wilmington, Delaware-headquartered producer of specialty active pharmaceutical ingredients (APIs), and SPI Pharma, a Wilmington, Delaware-headquartered manufacturer and supplier of functional excipient platforms and the development and...
Thermo Fisher Scientific is investing $50 million in its St. Louis, Missouri site, which is one of the company's Centers of Excellence (COE) for Biological Commercial Manufacturing. The investment is part of a strategy to expand the company's...
Lonza has partnered with Synpromics, an Edinburgh, UK-based synthetic promoter and gene-control company, to further develop Synpromics’ inducible promoter system and improve manufacturing of biopharmaceuticals. The 18-month project has been made...
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients, has completed the construction and validation of a new $3.2-million, 11,000-square-foot analytical laboratory at its High...
Porton Pharma Solutions, a Chongqing, China-headquartered pharmaceutical contract services provider, has partnered with Codexis, a Redwood City, California-headquartered protein engineering and biocatalyst company, to use Codexis’ biocatalyst...
Pall Corporation, a provider of filtration, separation, and purification products and services, has formed an agreement between its biotech business unit and Artesyn Biosolutions, a Waterford, Ireland-headquartered provider of single-use components...
